CDH1 and neoplasm: We also did the immunohistochemical (IHC) staining of xenograft tumours (Figure 7E,F), which showed that the EMT maker vimentin was down‐regulated (Figure 7E) in HULC‐depleted tumours but E‐cadherin was up‐regulated (Figure 7F), which agreed with the Western blotting results.